These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1768664)

  • 21. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study.
    Taylor JD; Kraft SP; Kazdan MS; Flanders M; Cadera W; Orton RB
    Can J Ophthalmol; 1991 Apr; 26(3):133-8. PubMed ID: 2054723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin in the treatment of facial dyskinesias.
    Chong PN; Ong B; Chan R
    Ann Acad Med Singap; 1991 Mar; 20(2):223-7. PubMed ID: 1883180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin A in clinical medicine.
    Elston JS
    J Physiol (Paris); 1990; 84(4):285-9. PubMed ID: 2079665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm.
    Kalra HK; Magoon EH
    Ophthalmic Surg; 1990 May; 21(5):335-8. PubMed ID: 2381655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term enhancement of botulinum toxin injections by upper-eyelid surgery in 14 patients with facial dyskinesias.
    Mauriello JA; Keswani R; Franklin M
    Arch Otolaryngol Head Neck Surg; 1999 Jun; 125(6):627-31. PubMed ID: 10367918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm.
    Berardelli A; Carta A; Stocchi F; Formica A; Agnoli A; Manfredi M
    Ital J Neurol Sci; 1990 Dec; 11(6):589-93. PubMed ID: 2081684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm.
    Ainsworth JR; Kraft SP
    Ophthalmology; 1995 Dec; 102(12):2036-40. PubMed ID: 9098314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
    Dutton JJ
    Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of botulinum toxin in blepharospasm and other facial spasms.
    Ruusuvaara P; Setälä K
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):313-9. PubMed ID: 3618155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment choices of 119 patients with hemifacial spasm over 11 years.
    Mauriello JA; Leone T; Dhillon S; Pakeman B; Mostafavi R; Yepez MC
    Clin Neurol Neurosurg; 1996 Aug; 98(3):213-6. PubMed ID: 8884091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of blepharospasm and facial hemispasm with botulinum toxin. Apropos of 58 injections in 22 patients].
    Elbaz D
    Ann Otolaryngol Chir Cervicofac; 1994; 111(3):141-4. PubMed ID: 7840486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections.
    Elston JS
    Br J Ophthalmol; 1987 Sep; 71(9):664-8. PubMed ID: 3663559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
    Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
    Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
    Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of facial spasm with botulinum toxin. An interim report.
    Frueh BR; Musch DC
    Ophthalmology; 1986 Jul; 93(7):917-23. PubMed ID: 3763137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P; Chaudhary M; Agrawal JP; Shah DN
    Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.